Based on their antitumor effects, HDAC inhibitors should be able to exert synergistic effects in combination with SE inhibitors (such as THZ1 and JQ1) and chemotherapies in neuroblastoma, glioblastoma, and other tumors72,105,112,113,146. This evidence concerns the gene HDAC9 and glioblastoma.